Day: May 17, 2022

Midland, TX, May 17, 2022 (GLOBE NEWSWIRE) —Stephen C. Taylor, after over 17 years of service to the Company, announces his retirement as President and Chief Executive Officer. He will remain Chairman as well as an advisor to the Company with a focus on long-term customer relationships.   John W. Chisholm, currently lead independent director, will serve as interim President and Chief Executive Officer, ensuring strong leadership continuity.Midland, TX, May 17, 2022 (GLOBE NEWSWIRE) — Natural Gas Services Group, Inc. (NYSE:NGS) (the “Company” or “NGS”), a leading provider of gas compression equipment and services to the natural gas and oil industry, announced today that Stephen C. Taylor, Chairman, President and Chief Executive Officer, will retire as President and Chief Executive Officer. He...

LAFAYETTE, Ind., May 17, 2022 (GLOBE NEWSWIRE) — Wabash (NYSE: WNC), the visionary leader of connected solutions for the transportation, logistics and distribution industries, today announced the creation of a new tech-enabled Wabash Parts distribution network. This will unify and expand Wabash’s parts distribution capabilities across all product lines, and provides immediate scale to grow. “As an end-to-end solutions and service provider, we’re able to offer customers the convenience of working with a one-stop-shop through the entire product lifecycle,” said Nick Adler, vice president of Wabash Parts and Services. “We’re excited to bring our customers best-in-class parts and services including a simplified experience, an extensive selection of well-stocked parts, and faster deliveries — all through Wabash.” This single channel...

ANN ARBOR, Mich., May 17, 2022 (GLOBE NEWSWIRE) — Kraig Biocraft Laboratories, Inc. (OTCQB: KBLB) (“Company” or “Kraig Labs”), the biotechnology company focused on the development and commercialization of spider silk, announces the first sample shipment of its recombinant spider silk fibers and fabrics for use and evaluation into a range of biomedical applications. This shipment was made in response to the significant increase in the requests for its propriety spider silk technology, over the last two quarters, for tissue engineering applications. Aided by its unique blend of mechanical and chemical properties, spider silk has long been recognized as an ideal natural biomaterial. As a lightweight, biocompatible, and biodegradable material, spider silk applications have been tested in numerous morphologies,...

InteliSwab test With less than one minute of “hands-on time,” the InteliSwab test is as simple as “Swab, Swirl, and See.”BETHLEHEM, Pa., May 17, 2022 (GLOBE NEWSWIRE) — OraSure Technologies, Inc. (NASDAQ: OSUR), a global leader in point-of-care and home diagnostic testing and sample collection technologies, announced today that its InteliSwab® COVID-19 rapid tests detect the Omicron BA.2, BA.2.12.1, BA.3 and BA.5 subvariants with similar levels of detection to the original SARS-CoV-2 strain and other previous variants of concern, including Delta, Alpha, Beta, Gamma and Omicron BA.1. The Omicron sublineage studies were conducted using live SARS-CoV-2 virus at an independent, third-party laboratory and showed InteliSwab® detected the Omicron variants at similar viral load levels, or limit of detection, as previous variants that...

Figure 1 Geology plan of the Abu Marawat Concession showing the location of the Rodruin projectFigure 2 Geological plan of the North Ridge, showing the location of holes ROD-072 and ROD-073Figure 3 Drilling hole ROD-072 in steep terrain on the North Ridge at RodruinVANCOUVER, British Columbia, May 17, 2022 (GLOBE NEWSWIRE) — Aton Resources Inc. (AAN: TSX-V) (“Aton” or the “Company”) is pleased to update investors on the latest assay results from the Phase 2 diamond drilling programme at its advanced Rodruin gold exploration project. Rodruin is located in the Company’s 100% owned Abu Marawat Concession (“Abu Marawat” or the “Concession”), in the Eastern Desert of Egypt. Highlights:        Diamond drilling is ongoing at Rodruin, with 38 drill holes now having been completed to date, ROD-048 and ROD-051 to ROD-087,...

Amryt Announces Details of EMA Contingent Value Rights Payment DUBLIN, Ireland, and Boston MA, May 17, 2022 Amryt (Nasdaq: AMYT), a global, commercial-stage biopharmaceutical company dedicated to acquiring, developing and commercializing novel treatments for rare diseases, announces that, following the CHMP positive opinion for Filsuvez® on April 22, 2022, the European Medicines Agency (EMA) Contingent Value Rights (“CVRs”) issued to those Amryt shareholders and option holders who held Amryt shares or options prior to the acquisition of Aegerion Pharmaceuticals, Inc. (“CVR Holders”) will now become payable. The total amount payable to CVR Holders will be approximately USD$5.7million. Each CVR Holder will be issued with one loan note of USD$0.0995 for each CVR they hold (each a “Loan Note”). The certificates for the Loan Notes will be held...